Sugi Predict

Sugi Predict / Targets / RPP30

RPP30

Ribonuclease P protein subunit p30 · P78346 · RPP30 on Sugi Atlas →

0 patent compounds predicted against RPP30, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to RPP30 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Effects of Liraglutide on ER Stress in Obese Patients With Type 2 Diabetes PHASE4UNKNOWN
Management of Retinitis Pigmentosa Via Combination of Wharton's Jelly-derived Mesenchymal Stem Cells and Magnovision PHASE3COMPLETED
Safety Evaluation of Gene Therapy in Leber Hereditary Optic Neuropathy (LHON) Patients PHASE1/PHASE2COMPLETED
BI-1910 as a Single Agent and in Combination With Pembrolizumab for the Treatment of Advanced Solid Tumors PHASE1/PHASE2ACTIVE_NOT_RECRUITING
Subtenon Autologous Platelet-Rich Plasma in Inherited and Degenerative Retinal Diseases PHASE1/PHASE2ACTIVE_NOT_RECRUITING
Clinical Study of EBV-LMP1 Targeted DNAzyme to Treat Nasopharyngeal Carcinoma PHASE1/PHASE2COMPLETED
A Repeat-Dose, Open-Label, Two Arm Safety and Efficacy Study of Two Doses of VP-001 Administered Intravitreally in Participants With Confirmed PRPF31 Mutation-Associated Retinal Dystrophy, Including Participants Previously Treated With VP001 PHASE1/PHASE2ACTIVE_NOT_RECRUITING
MAD of IVT VP-001 in PRPF31 Mutation-Associated Retinal Dystrophy Subjects (Wallaby) PHASE1COMPLETED
SAD of IVT VP-001 in PRPF31 Mutation-Associated Retinal Dystrophy Subjects PHASE1COMPLETED
Investigating the Effect of Vitamin A Supplementation on Retinitis Pigmentosa PHASE1COMPLETED
Evaluation of Safety of Ciliary Neurotrophic Factor Implants in the Eye PHASE1COMPLETED
Identifying Genes and Mutations Underlying Retinitis Pigmentosa and Allied Diseases nanUNKNOWN
Clinical Characterization on PDE6A-related Retinitis Pigmentosa in Preparation to a Gene Therapy Trial nanCOMPLETED
Natural History of PRPF31 Mutation-Associated Retinal Dystrophy nanACTIVE_NOT_RECRUITING
Management of Retinitis Pigmentosa Via Electromagnetic Stimulation and Platelet Rich Plasma nanCOMPLETED
Small RNA Pathways in Mammalian Gametogenesis nanCOMPLETED
InsightRP2 Registry nanRECRUITING
Molecular Genetics of Retinal Degenerations nanCOMPLETED
Differential Gene Expression of Liver Tissue and Blood From Individuals With Chronic Viral Hepatitis nanUNKNOWN
Clinical Manifestations and Biomarkers in Amyotrophic Lateral Sclerosis Type 4 and Other Inherited Neurological Disorders of RNA Processing nanRECRUITING
Management of Cystoid Macular Edema Secondary to Retinitis Pigmentosa Via Subliminal Micropulse Yellow Laser nanCOMPLETED
MiRNA223 and HMGB1 as Apredictos for Drug Resistant Epilepsy nanUNKNOWN
Role of SF3B1 Mutation in Assessment of Acute and Chronic Lymphatic Leukemia nanNOT_YET_RECRUITING
LINC00511/miR-185-3p Axis and miR-301a-3p Markers for Breast Cancer Diagnosis nanCOMPLETED
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
Effect of Adenovirus E1A Oncogene on DNA Replication Dynamics nanUNKNOWN
Understanding Clinical Phenotype and Collecting Biomarker Samples in C9ORF72 ALS nanCOMPLETED
Effects of Subtenon-injected Autologous Platelet-rich Plasma on Visual Functions in Eyes With Retinitis Pigmentosa nanCOMPLETED
Dentatorubral-pallidoluysian Atrophy Natural History and Biomarkers Study nanUNKNOWN
Advancing Research and Treatment for Frontotemporal Lobar Degeneration (ARTFL) nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a RPP30 binder may also engage these)

ProteinNameSimilarity
Q3SZ21 — 1.000 Q3SZ21 →
O88796 — 1.000 O88796 →
P87120 — 0.992 P87120 →
P09445 — 0.986 P09445 →
EEF2 Elongation factor 2 0.986 landscape →
Q84WU9 — 0.985 Q84WU9 →
Q9T079 — 0.985 Q9T079 →
Q7Q727 — 0.985 Q7Q727 →
P05197 — 0.985 P05197 →
Q5R8Z3 — 0.984 Q5R8Z3 →
P38786 — 0.984 P38786 →
P58252 — 0.984 P58252 →
Q8IUF1 — 0.984 Q8IUF1 →
P55823 — 0.984 P55823 →
A8WJ41 — 0.984 A8WJ41 →
Q9XX15 — 0.984 Q9XX15 →
Q9W3C1 — 0.984 Q9W3C1 →
Q3SYU2 — 0.984 Q3SYU2 →
Q19366 — 0.983 Q19366 →
Q9M2Q4 — 0.983 Q9M2Q4 →
Q5BKM6 — 0.983 Q5BKM6 →
Q16RF5 — 0.983 Q16RF5 →
A9VB27 — 0.983 A9VB27 →
G5EDZ2 — 0.983 G5EDZ2 →
Q5XI69 — 0.983 Q5XI69 →
F4IDQ6 — 0.983 F4IDQ6 →
Q9VHF2 — 0.983 Q9VHF2 →
Q8R2W9 — 0.983 Q8R2W9 →
TUFM Elongation factor Tu, mitochondrial 0.983 landscape →
P93834 — 0.983 P93834 →